Institute of General Pathology, Catholic University Medical School, Rome, Italy.
Cancer Metastasis Rev. 2010 Jun;29(2):351-78. doi: 10.1007/s10555-010-9225-4.
According to a "canonical" view, reactive oxygen species (ROS) positively contribute, in different ways, to carcinogenesis and to malignant progression of tumor cells: they drive genomic damage and genetic instability, transduce, as signaling intermediates, mitogenic and survival inputs by growth factor receptors and adhesion molecules, promote cell motility and shape the tumor microenvironment by inducing inflammation/repair and angiogenesis. Chemopreventive and tumor-inhibitory effects of endogenous, diet-derived or supplemented antioxidants largely support this notion. However, emerging lines of evidence indicates that tumor cells also need to defend themselves from oxidative damage in order to survive and successfully spread at distance. This "heresy" has recently received important impulse from studies on the role of antioxidant capacity in cancer stem cells self-renewal and resistance to therapy; additionally, the transforming activity of some oncogenes has been unexpectedly linked to their capacity to maintain elevated intracellular levels of reduced glutathione (GSH), the principal redox buffer. These studies underline the importance of cellular antioxidant capacity in metastasis, as the result of a complex cell program involving enhanced motility and a profound change in energy metabolism. The glycolytic switch (Warburg effect) observed in malignant tissues is triggered by mitochondrial oxidative damage and/or activation of redox-sensitive transcription factors, and results in an increase of cell resistance to oxidants. On the other hand, cytoskeleton rearrangement underlying cell motile and tumor-aggressive behavior use ROS as intermediates and are therefore facilitated by oxidative stress. Along this line of speculation, we suggest that metastasis represents an integrated strategy for cancer cells to avoid oxidative damage and escape excess ROS in the primary tumor site, explaning why redox signaling pathways are often up-regulated in malignancy and metastasis.
根据一种“规范”观点,活性氧(ROS)以不同的方式积极促进致癌作用和肿瘤细胞的恶性进展:它们驱动基因组损伤和遗传不稳定性,作为信号中间体转导生长因子受体和黏附分子的有丝分裂和存活输入,通过诱导炎症/修复和血管生成促进细胞迁移并塑造肿瘤微环境。内源性、饮食衍生或补充的抗氧化剂的化学预防和肿瘤抑制作用在很大程度上支持了这一观点。然而,新出现的证据表明,肿瘤细胞也需要保护自己免受氧化损伤,以便生存并成功远距离扩散。这种“异端邪说”最近受到关于抗氧化能力在癌症干细胞自我更新和对治疗的抵抗中的作用的研究的重要推动;此外,一些致癌基因的转化活性已被意外地与其维持细胞内还原型谷胱甘肽(GSH)水平升高的能力联系起来,GSH 是主要的氧化还原缓冲剂。这些研究强调了细胞抗氧化能力在转移中的重要性,这是一个涉及增强运动性和能量代谢深刻变化的复杂细胞程序的结果。恶性组织中观察到的糖酵解开关(Warburg 效应)是由线粒体氧化损伤和/或氧化还原敏感转录因子的激活触发的,导致细胞对氧化剂的抵抗力增加。另一方面,细胞迁移和肿瘤侵袭行为所必需的细胞骨架重排使用 ROS 作为中间体,因此受到氧化应激的促进。沿着这条推测思路,我们认为转移代表了癌细胞避免氧化损伤并从原发性肿瘤部位逃逸过多 ROS 的综合策略,解释了为什么氧化还原信号通路在恶性肿瘤和转移中经常上调。